A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
Clinical trial NCT05651932 · RECRUITING
Trial details
- NCT number
- NCT05651932
- Sponsor
- K36 Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-22
- Primary completion
- 2027-12-31
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.